Digital Therapeutics for Mental Health and Addiction

The State of the Science and Vision for the Future
Erscheinungsjahr 2022
ISBN: 978-0-323-90045-4
Verlag: Elsevier Science & Technology

Buch, Englisch, 220 Seiten, Format (B × H): 275 mm x 216 mm, Gewicht: 720 g

Digital Therapeutics for Mental Health and Addiction: The State of the Science and Vision for the Future presents the foundations of digital therapeutics with a broad audience in mind, ranging from bioengineers and computer scientists to those in psychology, psychiatry and social work. Sections cover cutting-edge advancements in the field, offering advice on how to successfully implement digital therapeutics. Readers will find sections on evidence for direct-to-consumer standalone digital therapeutics, the efficacy of integrating digital treatments within traditional healthcare settings, and recent innovations currently transforming the field of digital therapeutics towards experiences which are more personalized, adaptable and engaging.

This book gives a view on current limitations of the technology, ideas for problem-solving the challenges of designing this technology, and a perspective on future research directions. For all readers, the content on cultural, legal and ethical dimensions of digital mental health will be useful.

Autoren/Hrsg.

Marsch, Lisa A.

Jacobson, Nicholas C.

Kowatsch, Tobias

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Psychiatrie, Sozialpsychiatrie, Suchttherapie
• Mathematik | Informatik EDV | Informatik Angewandte Informatik Computeranwendungen in Wissenschaft & Technologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Medizinische Mathematik & Informatik
• Sozialwissenschaften Psychologie Psychotherapie / Klinische Psychologie Suchttherapie

Inhaltsverzeichnis

Section A. Introduction and Evidence Base 1. Need for a Paradigm Shift: Gaps and Failures in Traditional Mental Health and Addiction Treatments 2. Digital Therapeutics: A New Class of Tools for Old Problems 3. State of the Science of Internet-Based Programs for Direct-to-Consumer Standalone Care for Mental Health and Addiction 4. State of the Science of Mental Health and Addiction Treatment Apps for Direct-to-Consumer Standalone Care (Second Wave of Scalable Digital Therapeutics) 5. Blending Digital Therapeutics with Traditional Treatments within the Healthcare System

Section B. The New Frontier 6. Using Advances in Technology to Identify Digital Biomarkers to Improve Passive Patient Monitoring 7. Receptivity of Mobile Health Interventions 8. Analytics for Adapting Interventions to Context Targeting Vulnerability and Receptivity 9. Digital Therapeutic Alliance 10. The First Wave of Conversational Agents: Chatbots Embedded within Smartphones and the Internet 11. The Second Wave of Conversational Agents: Voice Assistants within Everyday Objects and the Internet of Things

Section C. Import Considerations 12. Cultural Adaptations of Digital Therapeutics 13. Implementation, Business Models, and Regulation 14. Lessons Learned and Potential Pitfalls 15. Privacy and Security 16. Ethical Considerations of Digital Therapeutics 17. Design Considerations for Preparation, Optimization, Evaluation and Maintaining Digital Therapeutics 18. Futuristic Vision 10-20 Years Out

Über Autor(innen)

Kowatsch, Tobias
Dr. Tobias Kowatsch is Assistant Professor for Digital Health at the University of St. Gallen and the Scientific Director of the Center for Digital Health Interventions, a joint initiative of the Department of Management, Technology and Economics at ETH Zurich and the Institute of Technology Management at the University of St. Gallen. In close collaboration with his interdisciplinary team and research partners, Tobias designs digital health interventions ("digital pills") at the intersection of information systems reserach, comuter science and behavioral medicine. He helped initiate and participates in the on-going development of MobileCoach, an open source platform for ecological momentary assessments, health monitoring and digital health interventions. He is also co-founder of the ETH Zurich and University of St. Gallen spin-off company Pathmate Technologies that creates and delivers digital clinical pathways.

Jacobson, Nicholas C.
Nick Jacobson is a tenure-track assistant professor in the departments of Biomedical Data Science and Psychiatry within the Center for Technology and Behavioral Health in the Geisel School of Medicine at Dartmouth College. He directs the AI and Mental Health: Innovation in Technology Guided Healthcare (AIM HIGH) Laboratory.

Dr. Jacobson researches the use of technology to enhance both the assessment and treatment of anxiety and depression. His work has focused on (1) enhancing precision assessment of anxiety and depression using intensive longitudinal data, (2) conducting multimethod assessment utilizing passive sensor data from smartphones and wearable devices, and (3) providing scalable, personalized technology-based treatments utilizing smartphones. He has a strong interest in creating personalized just-in-time adaptive interventions and the quantitative tools that make this work possible. To date, Dr. Jacobson's smartphone applications which assess and treat anxiety and depression have been downloaded and installed by more than 50,000 people in over 100 countries.